Cardiovascular Effects of TKIs in the Treatment of CML
Oct 31, 2017
Dr Christopher Plummer is a consultant cardiologist at the Freeman Hospital in Newcastle upon Tyne in the UK. He has a major clinical and research interest in cardiovascular effects of cancer treatments. He has co-written cardio-oncology guidance in 3 areas and given advice on more than 50 clinical trials. He is a founder member of the British Cardio-Oncology Society (BC-OS.org) whose mission is to promote research, best clinical practice and a wider understanding of the effects of cancer treatment on the cardiovascular system. His other interests include implantable cardiac rhythm device management, medical education and the use of information technology in medicine.